Although the 8-week landmark analysis showed a trend for improved PFS and development of hyperglycemia or hypercholesterolemia, the associations were not statistically significant.
← all excerpts
Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials.
1
—
—